224 related articles for article (PubMed ID: 2209315)
41. Dietary fish oil (MaxEPA) enhances pancreatic carcinogenesis in azaserine-treated rats.
Appel MJ; Woutersen RA
Br J Cancer; 1996 Jan; 73(1):36-43. PubMed ID: 8554980
[TBL] [Abstract][Full Text] [Related]
42. Fish oil diet rich in eicosapentaenoic acid increases bleeding time in the rat by interaction with sympathetic transmitters.
Juan H; Sametz W
Agents Actions; 1989 Aug; 28(1-2):130-6. PubMed ID: 2551150
[TBL] [Abstract][Full Text] [Related]
43. A comparison of the influence on plasma lipids and platelet function of supplements of omega 3 and omega 6 polyunsaturated fatty acids.
Sanders TA; Hochland MC
Br J Nutr; 1983 Nov; 50(3):521-9. PubMed ID: 6639916
[TBL] [Abstract][Full Text] [Related]
44. Effects of dietary selenium and fish oil (MaxEPA) on arachidonic acid metabolism and hemostatic function in rats.
Song J; Wander RC
J Nutr; 1991 Mar; 121(3):284-92. PubMed ID: 2002400
[TBL] [Abstract][Full Text] [Related]
45. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis--a double-blind placebo controlled study.
Lau CS; Morley KD; Belch JJ
Br J Rheumatol; 1993 Nov; 32(11):982-9. PubMed ID: 8220938
[TBL] [Abstract][Full Text] [Related]
46. Dose-response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridemia.
Stacpoole PW; Alig J; Ammon L; Crockett SE
Metabolism; 1989 Oct; 38(10):946-56. PubMed ID: 2677610
[TBL] [Abstract][Full Text] [Related]
47. Supplementation with EPA or fish oil for 11 months lowers circulating lipids, but does not delay the onset of diabetes in UC Davis-type 2 diabetes mellitus rats.
Cummings BP; Stanhope KL; Graham JL; Griffen SC; Havel PJ
Br J Nutr; 2010 Dec; 104(11):1628-34. PubMed ID: 20735878
[TBL] [Abstract][Full Text] [Related]
48. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
[TBL] [Abstract][Full Text] [Related]
49. Effects of a fish oil concentrate in patients with hypercholesterolemia.
Demke DM; Peters GR; Linet OI; Metzler CM; Klott KA
Atherosclerosis; 1988 Mar; 70(1-2):73-80. PubMed ID: 3355619
[TBL] [Abstract][Full Text] [Related]
50. Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM.
Westerveld HT; de Graaf JC; van Breugel HH; Akkerman JW; Sixma JJ; Erkelens DW; Banga JD
Diabetes Care; 1993 May; 16(5):683-8. PubMed ID: 8495604
[TBL] [Abstract][Full Text] [Related]
51. Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasis.
Yosefy C; Viskoper JR; Varon D; Ilan Z; Pilpel D; Lugassy G; Schneider R; Savyon N; Adan Y; Raz A
J Hum Hypertens; 1996 Sep; 10 Suppl 3():S135-9. PubMed ID: 8872845
[TBL] [Abstract][Full Text] [Related]
52. Metabolic effects of omega-3 fatty acids in type 2 (non-insulin-dependent) diabetic patients.
Pelikánová T; Kohout M; Válek J; Kazdová L; Base J
Ann N Y Acad Sci; 1993 Jun; 683():272-8. PubMed ID: 8251021
[TBL] [Abstract][Full Text] [Related]
53. Fish oil supplementation attenuates changes in plasma lipids caused by dexamethasone treatment in rats.
Barbosa AM; Francisco Pde C; Motta K; Chagas TR; Dos Santos C; Rafacho A; Nunes EA
Appl Physiol Nutr Metab; 2016 Apr; 41(4):382-90. PubMed ID: 26939043
[TBL] [Abstract][Full Text] [Related]
54. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects.
Meyer BJ; Hammervold T; Rustan AC; Howe PR
Lipids; 2007 Mar; 42(2):109-15. PubMed ID: 17393216
[TBL] [Abstract][Full Text] [Related]
55. Effect of dietary fish oil supplementation on peroxidation of serum lipids in patients with non-insulin dependent diabetes mellitus.
McGrath LT; Brennan GM; Donnelly JP; Johnston GD; Hayes JR; McVeigh GE
Atherosclerosis; 1996 Apr; 121(2):275-83. PubMed ID: 9125301
[TBL] [Abstract][Full Text] [Related]
56. Effects of n-3 fatty acid supplements on glycemic traits in Chinese type 2 diabetic patients: A double-blind randomized controlled trial.
Zheng JS; Lin M; Fang L; Yu Y; Yuan L; Jin Y; Feng J; Wang L; Yang H; Chen W; Li D; Tang J; Cai W; Shi M; Li Z; Wang F; Li D
Mol Nutr Food Res; 2016 Oct; 60(10):2176-2184. PubMed ID: 27279274
[TBL] [Abstract][Full Text] [Related]
57. Chronic effects of omega-3 fatty acids (fish oil) in a rat 5/6 renal ablation model.
Clark WF; Parbtani A; Philbrick DJ; Holub BJ; Huff MW
J Am Soc Nephrol; 1991 Jun; 1(12):1343-53. PubMed ID: 1912396
[TBL] [Abstract][Full Text] [Related]
58. Effect on blood lipids and haemostasis of a supplement of cod-liver oil, rich in eicosapentaenoic and docosahexaenoic acids, in healthy young men.
Sanders TA; Vickers M; Haines AP
Clin Sci (Lond); 1981 Sep; 61(3):317-24. PubMed ID: 6266735
[TBL] [Abstract][Full Text] [Related]
59. Does vegetable oil attenuate the beneficial effects of fish oil in reducing risk factors for cardiovascular disease?
Hwang DH; Chanmugam PS; Ryan DH; Boudreau MD; Windhauser MM; Tulley RT; Brooks ER; Bray GA
Am J Clin Nutr; 1997 Jul; 66(1):89-96. PubMed ID: 9209174
[TBL] [Abstract][Full Text] [Related]
60. Alpha-linolenic acid and marine long-chain n-3 fatty acids differ only slightly in their effects on hemostatic factors in healthy subjects.
Freese R; Mutanen M
Am J Clin Nutr; 1997 Sep; 66(3):591-8. PubMed ID: 9280178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
